WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1632972 PLYMOUTH, MN

Position in BMRN

as of Mar 31, 2026 · filed Apr 8, 2026 Compact

Position Value

$6,348,063

+$1,367,651 QoQ

Shares Held

112,375

+34.1% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 4.299888765294772.ToString("F0")% Shared 0.ToString("F0")% None 95.70011123470523.ToString("F0")%

Healthcare · as of Mar 31, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $121,469,578 across 107 Biotechnology names. BMRN ranks #5 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	37,596	$29,048,173
2	VRTX	Vertex Pharmaceuticals Inc / Ma	40,668	$18,159,888
3	INCY	Incyte Corp	146,306	$13,770,320
4	EXEL	Exelixis, Inc.	206,578	$8,860,130
5	BMRN	Biomarin Pharmaceutical Inc This page	112,375	$6,348,063
6	AXSM	Axsome Therapeutics, Inc.	19,180	$3,241,803
7	HALO	Halozyme Therapeutics, Inc.	46,665	$3,015,958
8	ALNY	Alnylam Pharmaceuticals, Inc.	8,478	$2,805,115

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,348,063	112,375	+34.1%	Shares	Sole	2026-04-08
2025-12-31	$4,980,412	83,803	-6.3%	Shares	Sole	2026-01-08
2025-09-30	$4,843,203	89,424	+20.2%	Shares	Sole	2025-10-29
2025-06-30	$4,088,723	74,381	+66.8%	Shares	Sole	2025-07-10
2025-03-31	$3,151,642	44,584	+92.2%	Shares	Sole	2025-04-16
2024-12-31	$1,525,001	23,201	+295.9%	Shares	Sole	2025-03-17
2024-09-30	$411,969	5,861	+64.1%	Shares	Sole	2024-10-24
2024-06-30	$294,082	3,572	—	Shares	Sole	2024-07-16
No filing history on record for this holder in this stock.